Intelligence Platform
Patents
Browse 3,494 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12343337
Compounds for increasing neural plasticity
granted patentUS 12345709
CLAUDIN18 antibodies and methods of treating cancer
granted patentUS 12329776
Treatment methods for ALS patients
granted patentUS 12332245
Cancer biomarkers and methods of use thereof
granted patentUS 12325710
Substituted 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles for treating brain disorders
granted patentUS 12325715
Fluorous metal chelates compositions
granted patentUS 12325755
Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics
granted patentUS 12318401
Injectable shear-thinning hydrogel containing therapeutic agent for enhanced tumor therapy
granted patentUS 12310954
Salivary gland regeneration
granted patentUS 12313635
Biomarker for thoracic aortic aneurysm
granted patentUS 12311169
Multi-site transcutaneous electrical stimulation of the spinal cord for facilitation of lo
granted patentUS 12312616
CRISPR-Cas effector polypeptides and methods of use thereof
granted patentUS 12310997
Compositions and methods of treating ocular diseases
granted patentUS 12310934
Methods of treatment of spontaneous preterm birth
granted patentUS 12311053
Nanotube-vesicle compositions and uses thereof
granted patentUS 12303479
Chloride intracellular channel 1 for regulation of food intake
granted patentUS 12296023
Chemically and photochemically initiated cell membrane blebbing to induce cell vesicle pro
granted patentUS 12295971
Compositions and methods for enhancing adoptive T cell therapeutics
granted patentUS 12297241
Method to engineer transplantable human tissues
granted patentUS 12297452
Methods or generating T-cells from stem cells and immunotherapeutic methods using the T-ce
granted patentUS 12292445
Methods of selecting subjects for treatment with metabolomic modulators
granted patentUS 12285472
Self-antigen displaying nanoparticles targeting auto-reactive immune factors and uses ther
granted patentUS 12286480
Modulators of ROR1-ROR2 binding
granted patentUS 12285404
Prevention of rosacea inflammation
granted